TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
1.341
+0.031 (2.38%)
Nov 5, 2024, 4:00 PM EST - Market closed
TNF Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 13 | 45 | 228 | - | - | |
| Market Cap Growth | -92.66% | -70.99% | -80.10% | - | - | - | |
| Enterprise Value | -10 | 6 | 39 | 213 | - | - | |
| Last Close Price | 1.31 | 7.76 | 34.50 | 181.80 | - | - | |
| Debt / Equity Ratio | 0.07 | 0.00 | 0.01 | 0.01 | -0.79 | -0.58 | |
| Debt / FCF Ratio | 0.00 | 0.00 | -0.01 | -0.01 | -0.89 | -0.19 | |
| Quick Ratio | 2.26 | 0.99 | 1.75 | 11.12 | 0.06 | 0.15 | |
| Current Ratio | 2.48 | 1.17 | 1.95 | 12.18 | 0.06 | 0.17 | |
| Return on Equity (ROE) | -297.63% | -29.12% | -79.27% | -325.06% | - | - | |
| Return on Assets (ROA) | -32.43% | -57.77% | -45.11% | -138.30% | -1227.92% | -1524.64% | |
| Return on Capital (ROIC) | -139.31% | -73.94% | -49.45% | -155.49% | - | - | |
| Buyback Yield / Dilution | -44.02% | -19.18% | -10.88% | -24.23% | 25.94% | - | |
| Total Shareholder Return | -44.02% | -19.18% | -10.88% | -24.23% | 25.94% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.